Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 5
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Impact of Lactic Acid Bacteria Fermentation on (Poly)Phenolic Profile and In Vitro Antioxidant and Anti-Inflammatory Properties of Herbal Infusions

  • Ozturk, Tarik
  • Ávila-Gálvez, María Ángeles
  • Mercier, Sylvie
  • Vallejo, Fernando
  • Bred, Alexis
  • Fraisse, Didier
  • Morand, Christine
  • Pelvan, Ebru
  • Monfoulet, Laurent-Emmanuel
  • González-Sarrías, Antonio
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/)., Recently, the development of functional beverages has been enhanced to promote health and nutritional well-being. Thus, the fermentation of plant foods with lactic acid bacteria can enhance their antioxidant capacity and others like anti-inflammatory activity, which may depend on the variations in the total content and profile of (poly)phenols. The present study aimed to investigate the impact of fermentation with two strains of Lactiplantibacillus plantarum of several herbal infusions from thyme, rosemary, echinacea, and pomegranate peel on the (poly)phenolic composition and whether lacto-fermentation can contribute to enhance their in vitro antioxidant and anti-inflammatory effects on human colon myofibroblast CCD18-Co cells. HPLC-MS/MS analyses revealed that fermentation increased the content of the phenolics present in all herbal infusions. In vitro analyses indicated that pomegranate infusion showed higher antioxidant and anti-inflammatory effects, followed by thyme, echinacea, and rosemary, based on the total phenolic content. After fermentation, despite increasing the content of phenolics, the antioxidant and anti-inflammatory effects via reduction pro-inflammatory markers (IL-6, IL-8 and PGE2) were similar to those of their corresponding non-fermented infusions, with the exception of a greater reduction in lacto-fermented thyme. Overall, the findings suggest that the consumption of lacto-fermented herbal infusions could be beneficial in alleviating intestinal inflammatory disorders., This project was funded by the European Union’s Horizon 2020 research and innovation programme under the PhenolAcTwin Project (Grant Agreement No: 951994). This work was supported by the grant TED2021-130962B-C22, funded by the MCIN/AEI/10.13039/501100011033 and by the “European Union NextGenerationEU/PRTR” program; the grant 22030/PI/22, funded by the Programa Regional de Fomento de la Investigación Científica y Técnica (Plan de Actuación 2022) de la Fundación Séneca-Agencia de Ciencia y Tecnología de la Región de Murcia, Spain; and the AGROALNEXT programme, supported by MCIN with funding from the European Union NextGenerationEU (PRTR-C17.I1) and Fundación Séneca, Comunidad Autónoma Región de Murcia (CARM)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

(R,S)-Equol 7-β-D-glucuronide, but not other circulating isoflavone metabolites, modulates migration and tubulogenesis in human aortic endothelial cells targeting the VEGF pathway

  • Giménez-Bastida, J. A.
  • Ávila-Gálvez, María Ángeles
  • Martínez-López, Alicia
  • García-Moreno, Diana
  • Espín de Gea, Juan Carlos
  • González-Sarrías, Antonio
Current knowledge indicates that the consumption of isoflavone-rich foodstuffs can have a beneficial impact on cardiovascular health. To what extent these isoflavones act as the main actors of that benefit is less clear. Genistein (GEN), daidzein (DAZ), and the DAZ-derived microbial metabolite equol (Eq) exhibit antiangiogenic effects in vitro, but their low bloodstream concentrations make it difficult to rationalize the in vivo effects. Their derived phase-II metabolites (glucuronides and sulfates) are major metabolites found in plasma, but their role as antiangiogenic molecules remains unexplored. We aimed here to first assess the anti-angiogenic activities of the main circulating isoflavone metabolites (glucuronides and sulfates) and compare them with their corresponding free forms at physiological concentrations (0.1–10 μM). The effects of the conjugated vs. free forms on tubulogenesis, cell migration, and VEGF-induced signalling were investigated in primary human aortic endothelial cells (HAECs). While (R,S)-equol 7-β-D-glucuronide (Eq 7-glur) exerted dose-dependent inhibition of tubulogenesis and endothelial migration comparable to that exerted by the free forms (GEN, DAZ, and Eq), the rest of the phase-II conjugates exhibited no significant effects. The underlying molecular mechanisms were independent of the bFGF but related to the modulation of the VEGF pathway. Besides, the observed dissimilar cellular metabolism (conjugation/deconjugation) places the phase-II metabolites as precursors of the free forms; however, the question of whether this metabolism impacts their biological activity requires additional studies. These new insights suggest that isoflavones and their circulating metabolites, including Eq 7-glur, may be involved in cardiovascular health (e.g., targeting angiogenesis), J. A. G.-B. was supported by a Standard European Marie Curie Individual Fellowship from the European Commission. D. G.-M. was supported by a Miguel Servet contract (AES 2021; CP21/00028) funded by the Institute Carlos III and by “ERDF a way of making Europe”. This work has received funding from the European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie Grant Agreement No. 838991. This work was supported by the Ramón y Cajal grant (RyC2021-032111-I) and by the grants CNS2022-135253 and TED2021-130962B-C22 funded by the MCIN/AEI/10.13039/501100011033 and by the “European Union NextGenerationEU/PRTR” program, grants PID2022-136915NA-I00 and PID2022-136419OB-I00 funded by MCIN/AEI/10.13039/501100011033 and “ERDF A way of making Europe” by the European Union, and the grant 22030/PI/22 funded by the Programa Regional de Fomento de la Investigación Científica y Técnica (Plan de Actuación 2022) de la Fundación Séneca-Agencia de Ciencia y Tecnología de la Región de Murcia, Spain, Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Metabolic Profiling of a Mediterranean-Inspired (Poly)phenol-Rich Mixture in the Brain: Perfusion Effect and In Vitro Blood-Brain Barrier Transport Validation

  • Ávila-Gálvez, María Ángeles
  • Garay-Mayol, Beatriz
  • Marín, Alicia
  • Brito, María Alexandra
  • Giménez-Bastida, J. A.
  • Espín de Gea, Juan Carlos
  • González-Sarrías, Antonio
A Mediterranean diet rich in (poly)phenols has been linked to neuroprotection, but its effects likely depend on the ability of phenolic metabolites to cross the blood-brain barrier (BBB). This study evaluated the kinetics plasma and brain distribution of phenolic metabolites in Sprague-Dawley rats following oral administration of a polyphenol-rich extract mixture from Mediterranean foods (pomegranate, lemon, orange, grape, and olive). UPLC-ESI-QTOF analyses revealed 39 phenolic-derived metabolites in plasma, of which 20 were in nonperfused (NPB) and 19 in perfused brains (PB), including hydroxytyrosol and tyrosol sulfates, ellagic acid, dihydrocaffeic acid, and derived metabolites. Kinetic data showed substantially higher plasma metabolite concentrations than the brain, with slightly higher levels in NPB. The BBB transport efficiency of phenolic metabolites was validated in vitro using human brain microvascular endothelial cells (HBMECs), showing improved transport when tested as mixtures. These findings confirm that circulating phenolic metabolites from Mediterranean foods can reach brain tissues, contributing to preventing neurodegenerative diseases., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Hydroxytyrosol Enhances Plasma Extracellular Vesicle Secretion, Modulates Their miRNAs Cargo, and Reduces LDL Oxidation in Humans: Postprandial and 1-Week Effects

  • Del Saz-Lara, Andrea
  • López de Las Hazas, María-Carmen
  • Tomé-Carneiro, Joao
  • Ávila-Gálvez, Maria-Ángeles
  • Crespo, María Carmen
  • Mazarío-Gárgoles, Carmen
  • Chapado, Luis A
  • Daimiel, Lidia
  • Visioli, Francesco
  • Martín-Santiago, Victoria
  • Espín de Gea, Juan Carlos
  • Dávalos, Alberto
Hydroxytyrosol (HT) consumption is associated with healthy outcomes. Specifically, its ability to modulate microRNA (miRNA) expression has been described. However, whether HT influences the secretion of extracellular vesicles (EVs) and their transported miRNAs remains unknown. Here, following HT administration, we explored the potential changes in EV secretion and in their miRNA cargo during postprandial state and after 1 week of daily intake. Twelve healthy participants received, first, a single 25 mg dose of HT (postprandial study) and then 25 mg HT daily, for one week (sustained study). Plasma and circulating plasma-isolated EVs were analyzed for HT and derived metabolites using UPLC-qTOF-MS and miRNAs by RNA-seq. HT induced the secretion of EVs 1-h post-ingestion and a 1-week daily administration of HT increased fasting EVs and reduced circulating oxidized LDL levels. RNA-seq analysis identified 55 modulated miRNAs (30 upregulated and 25 downregulated) related to response to oxygen level and gland development, following 1-week HT supplementation. This pilot study sheds light on the effects of HT consumption on EV secretion and modulation of exosomal miRNAs in humans, which has been scarcely studied to date. Further research is warranted to elucidate the molecular mechanisms underlying the observed effects., This research was funded by MCIN/ AEI /10.13039/501100011033 through the European and ERDF - “A way of making Europe” (PID2022-143100OB-I00 and PID2021-125899OB-I00), by the European Union NextGenerationEU/ PRTR (TED2021-130962B-C21 and TED2021-130962B-C22), by Comunidad de Madrid EXOHEP2-CM (S2022/BMD-7409), and by the AGROALNEXT program (MICIU, PRTR-C17.I1, Spain) with funding from the European Union NextGenerationEU (PRTR-C17.I1) and Fundación Séneca (Comunidad Autónoma Región de Murcia, Spain). M.C.L.H. is a recipient of a Ramon y Cajal Grant RYC2022-037626-I. C.M.-G. and L.B. are supported by a contract derived from Union NextGenerationEU/PRTR (TED2021-130962B-C21). A.S.-L. is supported by a predoctoral fellowship (N° 2021-01- PhD GRANT) from the International Olive Council. CIBEROBN (CB22/03/00068) is an initiative of the Instituto de Salud Carlos III, Spain. F.V. is partially funded by PRIN-2022 Prot. 2022NZNZH8., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Oral Delivery of Ellagic Acid Encapsulated in Milk Exosomes: Sex-Based Differences in Bioavailability, Urolithin Production, and Gut Microbiota Modulation

  • Ávila-Gálvez, María Ángeles
  • Romo-Vaquero, María
  • Mazarío-Gárgoles, Carmen
  • Tomé-Carneiro, Joao
  • López de Las Hazas, María-Carmen
  • Dávalos, Alberto
  • Selma, María Victoria
  • González-Sarrías, Antonio
  • Espín de Gea, Juan Carlos
Milk exosomes (EXOs) enhance polyphenols' bioavailability, but their potential for oral administration remains underexplored. Ellagic acid (EA) is poorly bioavailable. We investigate whether EA encapsulated in EXOs (EXO-EA) consumed orally improves EA bioavailability and (or) modulates gut microbiota. For 2 weeks, BALB/c mice received EXO, non-encapsulated EA (NEA), or EXO-EA (0.27 mg EA/kg bw) orally. Targeted and untargeted metabolomics (UPLC-qTOF-MS), fecal SCFAs (GC-MS), and gut microbiota (PacBio 16S-sequencing) were performed. Additionally, EA plasma and brain kinetics were evaluated in rats following intravenous administration of EXO-EA and NEA. Unlike NEA, EXO-EA quadrupled EA plasma levels in Sprague-Dawley rats and enabled brain detection. However, oral EXO-EA in mice failed to deliver EA systemically due to gastrointestinal instability, confirmed by in vitro digestion. Sex-dependent EXO-EA metabolomic effects were observed. Also, in males only, EXO-EA increased fecal urolithin A and SCFAs and enriched the microbiota with Christensenellaceae R7, Ruminococcus species, and Clostridium fusiformis, among others. In females, both EXO-EA and NEA enriched the microbiota with bifidobacteria, including Bifidobacterium pseudolongum. Oral EXO-EA impacted plasma metabolome, modulated gut microbiota, and increased urolithin A and SCFA production sex-dependently. However, gastrointestinal instability, limited EA encapsulation, and low dose administered prevented systemic delivery., This study was supported by Ministerio de Ciencia, Innovación y Universidades AGROALNEXT (PRTR-C17.I1), PID2022-136419OB-100, RYC2022-037626-I, TED2021-130962B-C21, and TED2021-130962B-C22, Fundación Séneca 22030/PI/22, AGROALNEXT (co-funding PRTR-C17.I1), Peer reviewed